Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

Announcement on Pegpesen's New Indication Obtaining Drug Clinical Trial Approval Notice

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Pegpesen's New Indication Obtaining Drug Clinical Trial Approval Notice

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment